live & interactive: A segment you don't want to miss!
Healthcare Analysts Tom Tobin and Andrew Freedman were live in studio today at 2:30PM ET detailing their latest thoughts in the Healthcare space and answering viewer questions live.
They discussed a conversation they recently had with an alternative pharmacy CEO familiar with Valeant (VRX) regarding the controversial practices all over the media. The core issue has yet to be covered despite the attention Valeant's Philador alternative pharmacy has received:
What is the underlying growth rate without it?
They also covered their outlook for Hologic (HOLX) earnings this week, as well as the #ACATaper theme as we head into Friday's U.S. Employment Report. Earnings reports so far in 3Q15 are confirming their #ACATaper thesis. The team also touched on MEDNAX (MD). According to their Maternity Tracker, maternity trends for MD are trending rapidly toward negative territory.